Sort
53,477 grants matching “addiction”
mHealth for Patient Self-Management of Opioid Use Disorder
$866,907Jennifer Sharpe Potter · Biomedical Development Corporation · R42 · FY2021 · DA
EOI::IMPLEMENTING THE PRESIDENT'S DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI MEDICATION DISCOVERY USING RAT MODELS OF RELAPSE. PERIOD OF PERFORMANCE: 7/10/
$866,812Virginia Commonwealth University · N01 · FY2025 · DA
Discovery and development of GPR3 agonists for nicotine cessation
$866,733Elaine Arrington Gay · Research Triangle Institute · R01 · FY2024 · DA
Molecular Codes for the Establishment of Functionally Segregated Dopaminergic Circuits
$866,354Hisashi Umemori · Boston Children'S Hospital · R01 · FY2021 · MH
Role of FH loss in development of HLRCC heriditary kidney cancer
$866,305Leonard Neckers · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Concept Project
$866,249Bryon H Adinoff · Ut Southwestern Medical Center · U10 · FY2006 · DA
Optimizing the use of ketamine to reduce chronic postsurgical pain
$866,163Jing Wang · New York University School Of Medicine · UH3 · FY2024 · CA
INTERACTION OF HIV MEDICATIONS WITH OPIATE THERAPY MEDICATIONS
$866,146Elinore F. McCance-Katz · Virginia Commonwealth University · M01 · FY2007 · RR
Targeting undruggable RAS for cancer treatment
$865,656Channing J Der · Univ Of North Carolina Chapel Hill · R35 · FY2024 · CA
Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment
$865,601Todd D Gould · University Of Maryland Baltimore · R01 · FY2020 · MH
Oral v Injection Naltrexone in Hospital: Comparative Effectiveness for Alcoholism
$865,396Richard Saitz · Boston University Medical Campus · R01 · FY2016 · AA
Immune Dysfunction in HIV+ Opioid Users
$865,279Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2024 · DA
5/6 HBCD Prenatal Experiences and Longitudinal Development (PRELUDE) Consortium
$865,180Weili Lin · Univ Of North Carolina Chapel Hill · U01 · FY2021 · DA
OpenBeds: Improving the Delivery of Care for Patients with Drug Addiction
$865,098Surendra Rawat · Openbeds, Inc. · R44 · FY2018 · DA
Administrative Core
$865,095Jasjit S Ahluwalia · Brown University · P20 · FY2024 · GM
Center for Addiction and Disease Risk Exacerbation
$865,095Peter M. Monti · Brown University · P20 · FY2024 · GM
J.P.Kennedy Mental Retardation and Developmental Disabilities Center
$864,639Nancy B Schwartz · University Of Chicago · P30 · FY2009 · HD
Harvard/Stanford GTN Program: Novel targeted therapeutics for glioblastoma
$864,597Tracy T Batchelor · Brigham And Women'S Hospital · U19 · FY2023 · CA
Real-Time Assessment of Drug Use, Along with Mental States and Environments
$864,537David Epstein · National Institute On Drug Abuse · ZIA · FY2025 · DA
New approaches to addiction treatment
$864,537David Epstein · National Institute On Drug Abuse · ZIA · FY2025 · DA
Characterization And Pharmacology Of Receptors For Gastrointestinal Peptides
$864,461R.t Jensen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Center for Advancing Longtiudinal Drug Abuse Research
$864,192Yih-Ing Hser · University Of California Los Angeles · P30 · FY2011 · DA
STRATEGIES TO TARGET METABOLIC ADDICTIONS IN BRAIN METASTATIC BREAST CANCER
$864,000Cold Spring Harbor Laboratory · · FY2021 · Defense Health Agency
Multiplex interrogation of neuromodulatory signaling in behaving animals with enhanced depth and resolution
$863,993Lin Tian · University Of California At Davis · U01 · FY2022 · NS
Characterization of neuronal ensembles activated during drug-induced behavior
$863,950Bruce Hope · National Institute On Drug Abuse · Z01 · FY2007 · DA